BCL2 and neoplasm: For the anticancer property, myricetin was recognized to be able to induce apoptosis of Human T24 bladder cancer cells via modulation of Bcl-2 family proteins and caspase-3, significantly inhibit the tumor growth on T24 bladder cancer xenografts model [8], and promote apoptosis through regulation of apoptotic protein Bax, Bad, and Bcl-2 in HepG2 cells [9].